Lindbrook Capital’s CEL-SCI Corp CVM Stock Holding History

Lindbrook Capital’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	-$1K	–	1750
2020 Q1	$1K	Buy	+3	New	+$1.1K	﹤0.01%	1425

Other funds holding CVM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Lindbrook Capital's CVM Position: Q2 2020 in Review

Lindbrook Capital sold out of CEL-SCI Corp (CVM) in Q2 2020, closing a stake of 3 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in CVM in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 96 funds tracked by Wall St. Rank hold CVM as of Q2 2020.

Lindbrook Capital reported no remaining CEL-SCI Corp position as of Q2 2020 after selling out during the quarter.
Lindbrook Capital sold 3 CEL-SCI Corp shares in Q2 2020, an estimated $1K.
Lindbrook Capital first reported a position in CEL-SCI Corp in Q1 2020 and held it in 1 quarter.
Lindbrook Capital's CEL-SCI Corp position peaked at $1K in Q1 2020.
96 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2020.

Based on Lindbrook Capital's 13F filing for Q2 2020, filed 27 Jul 2020.